|
Title
|
Published
|
Price
|
By
Wildwood Ventures Ltd
The Anemia Partnering 2007-2012 report provides understanding and access to the anemia partnering deals and agreements entered into by the worlds leading healthcare companies.Trends in anemia partnering deals Top anemia deals by value Deals liste
|
July
2012
|
$
995
|
By
Global Markets Direct
Aplastic Anemia – Pipeline Review, H1 2012
Summary
Global Markets Direct’s, ''Aplastic Anemia - Pipeline Review, H1 2012'', provides an overview of the Aplastic Anemia therapeutic pipeline. This report provides information on the therapeutic deve
|
June
2012
|
$
500
|
By
Global Markets Direct
Fanconi Anemia – Pipeline Review, H1 2012
Summary
Global Markets Direct’s, ''Fanconi Anemia - Pipeline Review, H1 2012'', provides an overview of the Fanconi Anemia therapeutic pipeline. This report provides information on the therapeutic develop
|
June
2012
|
$
500
|
By
Global Markets Direct
Iron Deficiency Anemia – Pipeline Review, H1 2012
Summary
Global Markets Direct’s, 'Iron Deficiency Anemia - Pipeline Review, H1 2012', provides an overview of the Iron Deficiency Anemia therapeutic pipeline. This report provides information on
|
April
2012
|
$
500
|
By
Global Markets Direct
Renal Anemia – Pipeline Review, H1 2012
Summary
Global Markets Direct’s, 'Renal anemia - Pipeline Review, H1 2012', provides an overview of the Renal anemia therapeutic pipeline. This report provides information on the therapeutic development f
|
March
2012
|
$
500
|
By
Global Markets Direct
Chemotherapy Induced Anemia – Pipeline Review, H1 2012
Summary
Global Markets Direct’s, 'Chemotherapy Induced Anemia - Pipeline Review, H1 2012', provides an overview of the Chemotherapy Induced Anemia therapeutic pipeline. This report provides
|
March
2012
|
$
500
|
By
Global Markets Direct
Anemia – Pipeline Review, H1 2012
Summary
Global Markets Direct’s, 'Anemia - Pipeline Review, H1 2012', provides an overview of the Anemia therapeutic pipeline. This report provides information on the therapeutic development for Anemia, complet
|
February
2012
|
$
500
|
By
GlobalData
GlobalData's clinical trial report, Anemia Global Clinical Trials Review, H1, 2012 provides data on the Anemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Anemia....
|
January
2012
|
$
1000
|
By
Global Markets Direct
Global Markets Direct’s, 'Acquired (Autoimmune) Hemolytic Anemia - Pipeline Review, H2 2011', provides an overview of the Acquired (Autoimmune) Hemolytic Anemia therapeutic pipeline. This report provides information on the therapeutic development for
|
November
2011
|
$
500
|
By
Global Markets Direct
Global Markets Direct’s, 'Renal Anemia - Pipeline Review, H2 2011', provides an overview of the Renal Anemia therapeutic pipeline. This report provides information on the therapeutic development for Renal Anemia, complete with latest updates, and spe
|
October
2011
|
$
500
|
By
Global Markets Direct
Global Markets Direct’s, 'Chemotherapy Induced Anemia - Pipeline Review, H2 2011', provides an overview of the Chemotherapy Induced Anemia therapeutic pipeline. This report provides information on the therapeutic development for Chemotherapy Induced
|
October
2011
|
$
500
|
By
Global Markets Direct
Global Markets Direct’s, '', provides an overview of the Anemia therapeutic pipeline. This report provid...
|
September
2011
|
$
500
|
By
GlobalData
GlobalData’s report “Erythropoiesis-Stimulating Agents in the Treatment of Chemotherapy Indu
|
August
2011
|
$
500
|
By
Global Markets Direct
Global Markets Direct’s, '', provides an overview of the Acquired (Autoi...
|
May
2011
|
$
500
|
By
Global Markets Direct
Global Markets Direct’s, '', provides an overview of the Iron Deficiency Anemia therapeutic pipeline. This report provide...
|
April
2011
|
$
500
|
By
Global Markets Direct
Global Markets Direct’s, '', provides an overview of the Renal anemia therapeutic pipeline. This report provides information on the therapeut...
|
March
2011
|
$
500
|
By
Global Markets Direct
Global Markets Direct’s, '', provides an overview of the Chemotherapy Induced Anemia therapeutic pipeline. This...
|
March
2011
|
$
500
|
By
Life Science Analytics
Life Science Analytics', contains detailed information on the anemia drug pipeline. This report provides ...
|
March
2011
|
$
1495
|
By
Global Markets Direct
Global Markets Direct’s, '', provides an overview of the Anemia therapeutic pipeline. This report provides information on the therapeutic development for...
|
February
2011
|
$
500
|
By
GlobalData
GlobalData's clinical trial report, provides data on the Anemia clinical trial scenario. This report provides in-depth information and data relating to the clini...
|
January
2011
|
$
1000
|
By
ICON Group International, Inc.
This econometric study covers the world outlook for Anemia drugs across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mil...
|
January
2011
|
$
795
|
By
ICON Group International, Inc.
This econometric study covers the latent demand outlook for Anemia drugs across the regions of Greater China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalities (Beijing, Chongqi...
|
January
2011
|
$
495
|
By
Global Markets Direct
Global Markets Direct’s, “Anemia Pipeline Review, Q4 2010”, provides an overview of the Anemia therapeutic pipeline. This report provides information on the therapeutic development for A...
|
December
2010
|
$
500
|